INBX
Inhibrx Biosciences
$111.42
−$1.44 (−1.28%)Sep 10, 2026
Key metrics
The numbers that frame INBX today
- Market cap
- $1.64B
- P/E (TTM)
- -11.9
- EV / FCF
- -12.8
- ROIC
- -90.5%
- Div yield
- 0%
- 52wk Low
- $26.19
- 52wk High
- $155.29
Growth
Revenue and earnings trend for INBX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about INBX
Is Inhibrx Biosciences a good buy?
Hold. Inhibrx Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Inhibrx Biosciences is selling at a high price.
What is the market capitalization of INBX?
Inhibrx Biosciences's market capitalization is $1.64B.
What is the P/E ratio for INBX stock?
Inhibrx Biosciences's current P/E ratio is -11.9.
What is the 52-week high for INBX stock?
The 52-week high for Inhibrx Biosciences is $155.29. The current close of $111.42 is 28.3% below that high.
What is the 52-week low for INBX stock?
The 52-week low for Inhibrx Biosciences is $26.19. The current close of $111.42 is 325.4% above that low.
Does INBX stock pay dividends?
Inhibrx Biosciences does not currently show a dividend per share in the company data.